Reckitt Benckiser Group plc is a British multinational consumer goods company best known for its portfolio of health, hygiene and nutrition brands. Headquartered in Slough, United Kingdom, the business was formed in 1999 through the merger of Reckitt & Colman plc and Benckiser NV. Reckitt’s shares trade on the London Stock Exchange and its American depositary receipts are available over the counter in the U.S. under the symbol RBGPF.
The company operates across three primary categories: health, hygiene and nutrition. In the health segment, Reckitt markets pain relief and cold remedies under brands such as Nurofen and Mucinex, along with throat lozenges like Strepsils. Its hygiene portfolio includes household cleaning and disinfectant products such as Lysol, Dettol and Harpic, while its nutrition business, bolstered by the 2017 acquisition of Mead Johnson Nutrition, offers infant formula products including Enfamil and Nutramigen.
Reckitt maintains a global footprint, serving consumers in approximately 200 countries and territories through a combination of direct operations and distributor partnerships. The group’s manufacturing and research facilities span Europe, North America, Asia Pacific and Latin America, reflecting a commitment to local market adaptation and innovation. Reckitt continually invests in research and development to advance formulations, improve sustainability and address emerging consumer health needs.
Under the leadership of Chief Executive Officer Laxman Narasimhan, who took the helm in September 2019, Reckitt has pursued both organic growth and strategic bolt-on acquisitions to strengthen its brand portfolio. The company’s executive team focuses on driving long-term value through margin expansion, digital commerce initiatives and heightened emphasis on environmental, social and governance (ESG) goals. Reckitt’s global management structure supports its ambition to deliver household essential products with a reputation for quality and reliability.
AI Generated. May Contain Errors.
